↑ トップへ　← 戻る

Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ, MAP2K

ABCDEFGH I JKLMNOPQRSTUVWXYZother

47 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related		 KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
2 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
3 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
4 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
5 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
6 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
7 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
8 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
9 Alcoholism 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
10 Alcoholism 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
11 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
12 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
13 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
14 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
15 Aldosterone-regulated sodium reabsorption 💬
 1件: NR3C2 💬 D01115 💬 Eplerenone 4件: 75, 113, 210, 215 💬
16 Alzheimer disease 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
17 Alzheimer disease 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
18 Amphetamine addiction 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
19 Amphetamine addiction 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
20 Amyotrophic lateral sclerosis 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
21 Amyotrophic lateral sclerosis 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
22 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
23 Apelin signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
24 Calcium signaling pathway 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
25 Calcium signaling pathway 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
26 Calcium signaling pathway 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
27 Calcium signaling pathway 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
28 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
29 Calcium signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
30 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
31 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
32 Calcium signaling pathway 💬
 4件: GRIN1, GRIN2A, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
33 Calcium signaling pathway 💬
 4件: GRIN1, GRIN2A, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
34 cAMP signaling pathway 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
35 cAMP signaling pathway 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
36 cAMP signaling pathway 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
37 cAMP signaling pathway 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
38 cAMP signaling pathway 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
39 cAMP signaling pathway 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
40 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
41 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
42 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
43 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
44 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
45 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
46 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
47 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
48 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
49 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
50 Circadian entrainment 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
51 Circadian entrainment 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
52 Cocaine addiction 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
53 Cocaine addiction 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
54 Complement and coagulation cascades 💬
 1件: PLG 💬 D01136 💬 Tranexamic acid 5件: 46, 70, 215, 227, 288 💬
55 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
56 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
57 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
58 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
59 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
60 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
61 Cushing syndrome 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
62 Cushing syndrome 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
63 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
64 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
65 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
66 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
67 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
68 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
69 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
70 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
71 Dopaminergic synapse 💬
 2件: GRIN2A, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
72 Dopaminergic synapse 💬
 2件: GRIN2A, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
73 Estrogen signaling pathway 💬
 1件: OPRM1 💬 D00320 💬 Fentanyl 4件: 46, 70, 215, 231 💬
74 Estrogen signaling pathway 💬
 1件: OPRM1 💬 D01399 💬 Fentanyl 4件: 46, 70, 215, 231 💬
75 Gap junction 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
76 Gap junction 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
77 Gap junction 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
78 Gap junction 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
79 Glutamatergic synapse 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
80 Glutamatergic synapse 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
81 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
82 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
83 Huntington disease 💬
 2件: GRIN1, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
84 Huntington disease 💬
 2件: GRIN1, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
85 Influenza A 💬
 1件: PLG 💬 D01136 💬 Tranexamic acid 5件: 46, 70, 215, 227, 288 💬
86 Long-term potentiation 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
87 Long-term potentiation 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
88 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
89 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
90 Morphine addiction 💬
 1件: OPRM1 💬 D00320 💬 Fentanyl 4件: 46, 70, 215, 231 💬
91 Morphine addiction 💬
 1件: OPRM1 💬 D01399 💬 Fentanyl 4件: 46, 70, 215, 231 💬
92 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
93 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
94 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
95 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
96 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
97 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
98 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
99 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
100 Neuroactive ligand-receptor interaction 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
101 Neuroactive ligand-receptor interaction 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
102 Neuroactive ligand-receptor interaction 💬
 1件: OPRM1 💬 D00320 💬 Fentanyl 4件: 46, 70, 215, 231 💬
103 Neuroactive ligand-receptor interaction 💬
 1件: OPRM1 💬 D01399 💬 Fentanyl 4件: 46, 70, 215, 231 💬
104 Neuroactive ligand-receptor interaction 💬
 1件: PLG 💬 D01136 💬 Tranexamic acid 5件: 46, 70, 215, 227, 288 💬
105 Nicotine addiction 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
106 Nicotine addiction 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
107 Pathways in cancer 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
108 Pathways in cancer 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
109 Pathways of neurodegeneration - multiple diseases 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
110 Pathways of neurodegeneration - multiple diseases 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
111 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
112 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
113 Prion disease 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
114 Prion disease 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
115 Rap1 signaling pathway 💬
 3件: GRIN1, GRIN2A, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
116 Rap1 signaling pathway 💬
 3件: GRIN1, GRIN2A, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
117 Ras signaling pathway 💬
 3件: GRIN1, GRIN2A, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
118 Ras signaling pathway 💬
 3件: GRIN1, GRIN2A, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
119 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
120 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
121 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
122 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
123 Renin secretion 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
124 Renin secretion 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
125 Renin secretion 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
126 Renin secretion 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
127 Renin secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
128 Renin secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
129 Renin-angiotensin system 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
130 Renin-angiotensin system 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
131 Salivary secretion 💬
 1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
132 Salivary secretion 💬
 1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
133 Salivary secretion 💬
 1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
134 Salivary secretion 💬
 1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
135 Spinocerebellar ataxia 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
136 Spinocerebellar ataxia 💬
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
137 Staphylococcus aureus infection 💬
 1件: PLG 💬 D01136 💬 Tranexamic acid 5件: 46, 70, 215, 227, 288 💬
138 Systemic lupus erythematosus 💬
 2件: GRIN2A, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
139 Systemic lupus erythematosus 💬
 2件: GRIN2A, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
140 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
141 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
142 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
143 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬

先頭へ